CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −473 | $30.68 | $15K | 19,607 |
| 2026-08-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −2,546 | 38,857 | ||
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +20,356 | $2.39 | $49K | 41,835 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −8,421 | $30.79 | $259K | 33,414 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,374 | $30.79 | $104K | 28,407 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,866 | $30.79 | $88K | 24,143 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −11,935 | $31.34 | $374K | 21,479 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −4,782 | $31.34 | $150K | 23,625 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −4,063 | $31.34 | $127K | 20,080 |
| 2026-08-04 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,356 | 41,403 | ||
| 2026-08-03 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −3,000 | $29.12 | $87K | 18,874 |
| 2026-08-03 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −4,486 | $30.00 | $135K | 14,388 |
| 2026-08-03 | Oelschlager Kristen M Chief Operating Officer | Sale 10b5-1 | −1,100 | $30.62 | $34K | 13,288 |
| 2026-08-03 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −1,730 | $28.25 | $49K | 78,995 |
| 2026-08-03 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +10,664 | $2.39 | $25K | 32,143 |
| 2026-08-03 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −10,664 | $30.35 | $324K | 21,479 |
| 2026-08-03 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −4,232 | $30.35 | $128K | 31,781 |
| 2026-08-03 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −3,597 | $30.35 | $109K | 27,009 |
| 2026-08-03 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −10,664 | 61,759 | ||
| 2026-07-31 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −8,149 | $28.84 | $235K | 89,886 |
Page 5 of 45 · 897 trades